MedTrace Logo

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up

NCT05784558 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-03-11

No results posted yet for this study

Summary

The objective of the RELIEF Study is to compare the safety, effectiveness and patient experience outcomes in real-world subjects treated with different modalities for symptomatic BPH.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

UroLift System

The UroLift System is a procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra.

OTHER

Watchful Waiting or BPH Medications

Subjects for whom the physician decides the best course of therapy to be either watchful waiting or new or continuing BPH medications.

DEVICE

Other Surgical Intervention

Physician decides the best course of therapy to be a surgical intervention other than the UroLift System.

Sponsors & Collaborators

  • NeoTract, Inc.

    lead INDUSTRY

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-26
Primary Completion
2026-01-26
Completion
2026-09-24
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784558 on ClinicalTrials.gov